Keeping your strength up: induced pluripotent stem cell-based approaches for the treatment and investigation of skeletal muscle disorders

References

• Ahmad I, Goel D, Ghosh A, Kapoor H, Kumar D, Ramesh K, Ashley B, Deepika K, Shastry A, Faruq M. 2022. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene. Stem Cell Res. 64:102927.
   PubMed Web of Science ®Google Scholar
• Al Tanoury Z, Rao J, Tassy O, Gobert B, Gapon S, Garnier JM, Wagner E, Hick A, Hall A, Gussoni E, Pourquié O. 2020. Differentiation of the human PAX7-positive myogenic precursors/satellite cell lineage in vitro. Development. 147(12).
   PubMed Web of Science ®Google Scholar
• Al Tanoury Z, Zimmerman JF, Rao J, Sieiro D, McNamara HM, Cherrier T, Rodríguez-delaRosa A, Hick-Colin A, Bousson F, Fugier-Schmucker C, et al. 2021. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro. Proc Natl Acad Sci U S A. 118(28).
   PubMed Web of Science ®Google Scholar
• Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 321(5889):699–702.
   PubMed Web of Science ®Google Scholar
• Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, Abe M. 2013. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. 494(7435):100–104.
   PubMed Web of Science ®Google Scholar
• Baci D, Chirivì M, Pace V, Maiullari F, Milan M, Rampin A, Somma P, Presutti D, Garavelli S, Bruno A, Cannata S. 2020. Extracellular vesicles from skeletal muscle cells efficiently promote myogenesis in induced pluripotent stem cells. Cells. 9(6).
   PubMed Web of Science ®Google Scholar
• Badiola-Mateos M, Osaki T, Kamm RD, Samitier J. 2022. In vitro modelling of human proprioceptive sensory neurons in the neuromuscular system. Sci Rep. 12(1):21318.
   PubMed Web of Science ®Google Scholar
• Bao X, Zhu X, Liao B, Benda C, Zhuang Q, Pei D, Qin B, Esteban MA. 2013. MicroRNAs in somatic cell reprogramming. Curr Opin Cell Biol. 25(2):208–214.
   PubMed Web of Science ®Google Scholar
• Barbeau S, Tahraoui-Bories J, Legay C, Martinat C. 2020. Building neuromuscular junctions in vitro. Development. 147(22).
   PubMed Web of Science ®Google Scholar
• Biressi S, Filareto A, Rando TA. 2020. Stem cell therapy for muscular dystrophies. J Clin Invest. 130(11):5652–5664.
   PubMed Web of Science ®Google Scholar
• Bosse MJ, MacKenzie EJ, Kellam JF, Burgess AR, Webb LX, Swiontkowski MF, Sanders RW, Jones AL, McAndrew MP, Patterson BM, et al. 2002. An analysis of outcomes of reconstruction or amputation after leg-threatening injuries. N Engl J Med. 347(24):1924–1931.
   PubMed Web of Science ®Google Scholar
• Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K. 2021. Life expectancy in duchenne muscular dystrophy. Neurology. 97(23):e2304–e2314.
   PubMed Web of Science ®Google Scholar
• Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F. 2003. The formation of skeletal muscle: from somite to limb. J Anat. 202(1):59–68.
   PubMed Web of Science ®Google Scholar
• Buckingham M, Relaix F. 2007. The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu Rev Cell Dev Biol. 23:645–673.
   PubMed Web of Science ®Google Scholar
• Caputo L, Granados A, Lenzi J, Rosa A, Ait-Si-Ali S, Puri PL, Albini S. 2020. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFbeta-dependent pro-fibrotic signaling. Skelet Muscle. 10(1):13.
   PubMed Web of Science ®Google Scholar
• Carlson BM, Faulkner JA. 1983. The regeneration of skeletal muscle fibers following injury: a review. Med Sci Sports Exerc. 15(3):187–198.
   PubMed Web of Science ®Google Scholar
• Chal J, Al Tanoury Z, Hestin M, Gobert B, Aivio S, Hick A, Cherrier T, Nesmith AP, Parker KK, Pourquié O. 2016. Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro. Nat Protoc. 11(10):1833–1850.
   PubMed Web of Science ®Google Scholar
• Chal J, Al Tanoury Z, Oginuma M, Moncuquet P, Gobert B, Miyanari A, Tassy O, Guevara G, Hubaud A, Bera A, Sumara O. 2018. Recapitulating early development of mouse musculoskeletal precursors of the paraxial mesoderm in vitro. Development. 145(6).
   PubMed Web of Science ®Google Scholar
• Chan SSK, Arpke RW, Filareto A, Xie N, Pappas MP, Penaloza JS, Perlingeiro RC, Kyba M. 2018. Skeletal muscle stem cells from PSC-derived teratomas have functional regenerative capacity. Cell Stem Cell. 23(1):74–85e6.
   PubMed Web of Science ®Google Scholar
• Chen Z, Li B, Zhan RZ, Rao L, Bursac N. 2021. Exercise mimetics and JAK inhibition attenuate IFN-gamma-induced wasting in engineered human skeletal muscle. Sci Adv. 7(4).
   Web of Science ®Google Scholar
• Choi S, Ferrari G, Moyle LA, Mackinlay K, Naouar N, Jalal S, Benedetti S, Wells C, Muntoni F, Tedesco FS. 2022. Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling. EMBO Mol Med. e14526.
   PubMed Web of Science ®Google Scholar
• Corona BT, Rivera JC, Owens JG, Wenke JC, Rathbone CR. 2015. Volumetric muscle loss leads to permanent disability following extremity trauma. J Rehabil Res Dev. 52(7):785–792.
   PubMedGoogle Scholar
• Corona BT, Wenke JC, Ward CL. 2016. Pathophysiology of volumetric muscle loss injury. Cells Tissues Organs. 202(3-4):180–188.
   PubMed Web of Science ®Google Scholar
• Cosgrove BD, Gilbert PM, Porpiglia E, Mourkioti F, Lee SP, Corbel SY, Llewellyn ME, Delp SL, Blau HM. 2014. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med. 20(3):255–264.
   PubMed Web of Science ®Google Scholar
• Court-Brown CM, McBirnie J. 1995. The epidemiology of tibial fractures. J Bone Joint Surg Br. 77(3):417–421.
   PubMedGoogle Scholar
• Cretoiu D, Pavelescu L, Duica F, Radu M, Suciu N, Cretoiu SM. 2018. Myofibers. Adv Exp Med Biol. 1088:23–46.
   PubMed Web of Science ®Google Scholar
• Dahlke J, Schott JW, Vollmer Barbosa P, Klatt D, Selich A, Lachmann N, Morgan M, Moritz T, Schambach A. 2021. Efficient genetic safety switches for future application of iPSC-derived cell transplants. J Pers Med. 11(6).
   PubMed Web of Science ®Google Scholar
• D’Amario D, Amodeo A, Adorisio R, Tiziano FD, Leone AM, Perri G, Bruno P, Massetti M, Ferlini A, Pane M, et al. 2017. A current approach to heart failure in Duchenne muscular dystrophy. Heart. 103(22):1770–1779.
   PubMed Web of Science ®Google Scholar
• Danisovic L, Culenova M, Csobonyeiova M. 2018. Induced pluripotent stem cells for duchenne muscular dystrophy modeling and therapy. Cells. 7(12).
   PubMed Web of Science ®Google Scholar
• Darabi R, Arpke R, Irion S, Dimos J, Grskovic M, Kyba M, Perlingeiro RR. 2012. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell. 10(5):610–619.
   PubMed Web of Science ®Google Scholar
• Darabi R, Santos FNC, Filareto A, Pan W, Koene R, Rudnicki MA, Kyba M, Perlingeiro RCR. 2011. Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells. 29(5):777–790.
   PubMed Web of Science ®Google Scholar
• De Luca A. 2012. Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. Acta Myol. 31(1):40–47.
   PubMedGoogle Scholar
• de Wert G, Mummery C. 2003. Human embryonic stem cells: research, ethics and policy. Hum Reprod. 18(4):672–682.
   PubMed Web of Science ®Google Scholar
• Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. 1997. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90(4):717–727.
   PubMed Web of Science ®Google Scholar
• Dellavalle A, Maroli G, Covarello D, Azzoni E, Innocenzi A, Perani L, Antonini S, Sambasivan R, Brunelli S, Tajbakhsh S, Cossu G. 2011. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun. 2:499.
   PubMed Web of Science ®Google Scholar
• Dhawan J, Rando TA. 2005. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 15(12):666–673.
   PubMed Web of Science ®Google Scholar
• Ding S, Dai Q, Huang H, Xu Y, Zhong C. 2018. An Overview of Muscle Atrophy. Adv Exp Med Biol. 1088:3–19.
   PubMed Web of Science ®Google Scholar
• Domenig SA, Bundschuh N, Lenardič A, Ghosh A, Kim I, Qabrati X, D'Hulst G, Bar-Nur O. 2022. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy. Stem Cell Rep. 17(2):321–336.
   PubMed Web of Science ®Google Scholar
• Dzierlega K, Yokota T. 2020. Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy. Gene Ther. 27(9):407–416.
   PubMed Web of Science ®Google Scholar
• Dziki J, Badylak S, Yabroudi M, Sicari B, Ambrosio F, Stearns K, Turner N, Wyse A, Boninger ML, Brown EH, Rubin JP. 2016. An acellular biologic scaffold treatment for volumetric muscle loss: results of a 13-patient cohort study. NPJ Regen Med. 1:16008.
   PubMed Web of Science ®Google Scholar
• Edgerton VR, Smith JL, Simpson DR. 1975. Muscle fibre type populations of human leg muscles. Histochem J. 7(3):259–266.
   PubMedGoogle Scholar
• Emery AE. 2002. The muscular dystrophies. Lancet. 359(9307):687–695.
   PubMed Web of Science ®Google Scholar
• Eser G, Topaloglu H. 2022. Current outline of exon skipping trials in duchenne muscular dystrophy. Genes (Basel). 13(7).
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Yamamoto R, Kubota T, Tazumi A, Sabuta T, Takahashi MP, Sakurai H. 2022. Mature myotubes generated from human-induced pluripotent stem cells without forced gene expression. Front Cell Dev Biol. 10:886879.
   PubMed Web of Science ®Google Scholar
• Gartz M, Lin CW, Sussman MA, Lawlor MW, Strande JL. 2020. Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy. Dis Model Mech. 13(11).
   PubMed Web of Science ®Google Scholar
• Ghori FF, Wahid M. 2021. Induced pluripotent stem cells from urine of Duchenne muscular dystrophy patients. Pediatr Int. 63(9):1038–1047.
   PubMed Web of Science ®Google Scholar
• Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. 1997. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 90(4):729–738.
   PubMed Web of Science ®Google Scholar
• Greising SM, Weiner JI, Garry DJ, Sachs DH, Garry MG. 2022. Human muscle in gene edited pigs for treatment of volumetric muscle loss. Front Genet. 13:948496.
   PubMed Web of Science ®Google Scholar
• Guan J, Liu X, Zhang H, Yang X, Ma Y, Li Y, Gai Z, Liu Y. 2020. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene. Stem Cell Res. 42:101666.
   PubMed Web of Science ®Google Scholar
• Henry CC, Martin KS, Ward BB, Handsfield GG, Peirce SM, Blemker SS. 2017. Spatial and age-related changes in the microstructure of dystrophic and healthy diaphragms. PLoS One. 12(9):e0183853.
   PubMed Web of Science ®Google Scholar
• Hicks M, Pyle A. 2015. The path from pluripotency to skeletal muscle: developmental myogenesis guides the Way. Cell Stem Cell. 17(3):255–257.
   PubMed Web of Science ®Google Scholar
• Hoffman EP. 2020. Pharmacotherapy of duchenne muscular dystrophy. Handb Exp Pharmacol. 261:25–37.
   PubMedGoogle Scholar
• Hong Y, Wang Y, Zhang Y, Royer JA, Cai B, Mann JR, McDermott S. 2019. Risk factors for falls among boys under 18 years with muscular dystrophy. J Pediatr Rehabil Med. 12(1):3–10.
   PubMed Web of Science ®Google Scholar
• Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M. 2014. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl Med. 3(5):564–574.
   PubMed Web of Science ®Google Scholar
• Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, et al. 2013. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 341(6146):651–654.
   PubMed Web of Science ®Google Scholar
• Houweling PJ, Coles CA, Tiong CF, Nielsen B, Graham A, McDonald P, Suter A, Piers AT, Forbes R, Ryan MM, et al. 2021. Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient. Stem Cell Res. 54:102429.
   PubMed Web of Science ®Google Scholar
• Huynh T, Reed C, Blackwell Z, Phelps P, Herrera LCP, Almodovar J, Zaharoff DA, Wolchok J. 2023. Local IL-10 delivery modulates the immune response and enhances repair of volumetric muscle loss muscle injury. Sci Rep. 13(1):1983.
   PubMed Web of Science ®Google Scholar
• Iftikhar M, Frey J, Shohan MJ, Malek S, Mousa SA. 2021. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. Pharmacol Ther. 220:107719.
   PubMed Web of Science ®Google Scholar
• Ismaeel A, Kim JS, Kirk JS, Smith RS, Bohannon WT, Koutakis P. 2019. Role of transforming growth factor-beta in skeletal muscle fibrosis: A review. Int J Mol Sci. 20(10).
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Ichihara Y, Morino K, Lemecha M, Sugawara L, Sawano T, Miake J, Sakurai H, Nishi E, Maegawa H, Imamura T. 2021. MicroRNA-494-3p inhibits formation of fast oxidative muscle fibres by targeting E1A-binding protein p300 in human-induced pluripotent stem cells. Sci Rep. 11(1):1161.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Imamura T, Morino K, Shimosato T, Tawa M, Ugi S, Sakurai H, Maegawa H, Okamura T. 2015. MicroRNA-494 plays a role in fiber type-specific skeletal myogenesis in human induced pluripotent stem cells. Biochem Biophys Res Commun. 468(1-2):208–213.
   PubMed Web of Science ®Google Scholar
• Jarrige M, Frank E, Herardot E, Martineau S, Darle A, Benabides M, Domingues S, Chose O, Habeler W, Lorant J, Baldeschi C. 2021. The future of regenerative medicine: cell therapy using pluripotent stem cells and acellular therapies based on extracellular vesicles. Cells. 10(2).
   PubMed Web of Science ®Google Scholar
• Jin Y, Shen Y, Su X, Weintraub NL, Tang Y. 2020. Effective restoration of dystrophin expression in iPSC (Mdx)-derived muscle progenitor cells using the CRISPR/Cas9 system and homology-directed repair technology. Comput Struct Biotechnol J. 18:765–773.
   PubMed Web of Science ®Google Scholar
• Jodat YA, Zhang T, Al Tanoury Z, Kamperman T, Shi K, Huang Y, Panayi A, Endo Y, Wang X, Quint J, Arnaout A. 2021. hiPSC-derived 3D bioprinted skeletal muscle tissue implants regenerate skeletal muscle following volumetric muscle loss. Res Sq. doi:10.21203/rs.3.rs-146091/v1.
   Google Scholar
• Joe AWB, Yi L, Natarajan A, Le Grand F, So L, Wang J, Rudnicki MA, Rossi FMV. 2010. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol. 12(2):153–163.
   PubMed Web of Science ®Google Scholar
• Judson RN, Rossi FMV. 2020. Towards stem cell therapies for skeletal muscle repair. NPJ Regen Med. 5:10.
   PubMed Web of Science ®Google Scholar
• Jung DW, Kim WH, Williams DR. 2014. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming. ACS Chem Biol. 9(1):80–95.
   PubMed Web of Science ®Google Scholar
• Kadi F, Schjerling P, Andersen LL, Charifi N, Madsen JL, Christensen LR, Andersen JL. 2004. The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J Physiol. 558(Pt 3):1005–1012.
   PubMed Web of Science ®Google Scholar
• Kaiser AD, Assenmacher M, Schröder B, Meyer M, Orentas R, Bethke U, Dropulic B. 2015. Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Ther. 22(2):72–78.
   PubMed Web of Science ®Google Scholar
• Khurana TS, Prendergast RA, Alameddine HS, Tomé FM, Fardeau M, Arahata K, Sugita H, Kunkel LM. 1995. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med. 182(2):467–475.
   PubMed Web of Science ®Google Scholar
• Kim E, Wu F, Wu X, Choo HJ. 2020. Generation of craniofacial myogenic progenitor cells from human induced pluripotent stem cells for skeletal muscle tissue regeneration. Biomaterials. 248:119995.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim SW, Lee SH, Jung DW, Williams DR. 2022a. Inhibiting 5-lipoxygenase prevents skeletal muscle atrophy by targeting organogenesis signalling and insulin-like growth factor-1. J Cachexia Sarcopenia Muscle. n/a(n/a).
   Google Scholar
• Kim JY, Nam Y, Rim YA, Ju JH. 2022b. Review of the current trends in clinical trials involving induced pluripotent stem cells. Stem Cell Rev Rep. 18(1):142–154.
   PubMed Web of Science ®Google Scholar
• Kim KM, Jang HC, Lim S. 2016. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 31(4):643–650.
   PubMed Web of Science ®Google Scholar
• Koh CH, Wu J, Chung YY, Liu Z, Zhang R-R, Chong K, Korzh V, Ting S, Oh S, Shim W, et al. 2017. Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides. Sci Rep. 7(1):2465.
   PubMedGoogle Scholar
• Koike H, Manabe I, Oishi Y. 2022. Mechanisms of cooperative cell-cell interactions in skeletal muscle regeneration. Inflamm Regen. 42(1):48.
   PubMed Web of Science ®Google Scholar
• Kostallari E, Baba-Amer Y, Alonso-Martin S, Ngoh P, Relaix F, Lafuste P, Gherardi RK. 2015. Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence. Development. 142(7):1242–1253.
   PubMed Web of Science ®Google Scholar
• Kuang S, Kuroda K, Le Grand F, Rudnicki MA. 2007. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 129(5):999–1010.
   PubMed Web of Science ®Google Scholar
• Kuo IY, Ehrlich BE. 2015. Signaling in muscle contraction. Cold Spring Harb Perspect Biol. 7(2):a006023.
   PubMed Web of Science ®Google Scholar
• Landfeldt E, Thompson R, Sejersen T, McMillan HJ, Kirschner J, Lochmüller H. 2020. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol. 35(7):643–653.
   PubMed Web of Science ®Google Scholar
• Langridge B, Griffin M, Butler PE. 2021. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches. J Mater Sci Mater Med. 32(1):15.
   PubMed Web of Science ®Google Scholar
• Latroche C, Gitiaux C, Chrétien F, Desguerre I, Mounier R, Chazaud B. 2015. Skeletal muscle microvasculature: A highly dynamic lifeline. Physiology (Bethesda). 30(6):417–427.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim BJ, Park DR, Kim UH. 2018. Exercise induces muscle fiber type switching via transient receptor potential melastatin 2-dependent Ca(2+) signaling. J Appl Physiol (1985). 124(2):364–373.
   PubMed Web of Science ®Google Scholar
• Lepper C, Conway SJ, Fan CM. 2009. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature. 460(7255):627–631.
   PubMed Web of Science ®Google Scholar
• Lepper C, Partridge TA, Fan CM. 2011. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development. 138(17):3639–3646.
   PubMed Web of Science ®Google Scholar
• Lim H, Choi IY, Hyun S-H, Kim H, Lee G. 2021. Approaches to characterize the transcriptional trajectory of human myogenesis. Cell Mol Life Sci. 78(9):4221–4234.
   PubMed Web of Science ®Google Scholar
• Lim KRQ, Yoon C, Yokota T. 2018. Applications of CRISPR/Cas9 for the treatment of duchenne muscular dystrophy. J Pers Med. 8(4).
   Web of Science ®Google Scholar
• Lin C-H, Lin Y-T, Yeh J-T, Chen C-T. 2007. Free functioning muscle transfer for lower extremity posttraumatic composite structure and functional defect. Plast Reconstr Surg. 119(7):2118–2126.
   PubMed Web of Science ®Google Scholar
• Lin CY, Yoshida M, Li LT, Ikenaka A, Oshima S, Nakagawa K, Sakurai H, Matsui E, Nakahata T, Saito MK. 2019. iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases. JCI Insight. 4(18).
   Web of Science ®Google Scholar
• Lin CY, Yoshida M, Li LT, Saito MK. 2020. In vitro neuromuscular junction induced from human induced pluripotent stem cells. J Vis Exp. 166.
   Google Scholar
• Liu ML, Zang T, Zhang CL. 2016. Direct lineage reprogramming reveals disease-specific phenotypes of motor neurons from human ALS patients. Cell Rep. 14(1):115–128.
   PubMed Web of Science ®Google Scholar
• Luttrell SM, Smith AST, Mack DL. 2021. Creating stem cell-derived neuromuscular junctions in vitro. Muscle Nerve. 64(4):388–403.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang H, Li X, Yang X, Li Y, Guan J, Lv Y, Gai Z, Liu Y. 2020. An integration-free iPSC line (SDQLCHi017-A) derived from a patient with nemaline myopathy-2 disease carrying compound heterozygote mutations in NEB gene. Stem Cell Res. 43:101729.
   PubMed Web of Science ®Google Scholar
• Maffioletti SM, Sarcar S, Henderson ABH, Mannhardt I, Pinton L, Moyle LA, Steele-Stallard H, Cappellari O, Wells KE, Ferrari G, et al. 2018. Three-Dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering. Cell Rep. 23(3):899–908.
   PubMed Web of Science ®Google Scholar
• Mah JK. 2018. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy. Methods Mol Biol. 1687:3–17.
   PubMedGoogle Scholar
• Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, et al. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 1(1):55–70.
   PubMed Web of Science ®Google Scholar
• Mashinchian O, De Franceschi F, Nassiri S, Michaud J, Migliavacca E, Aouad P, Metairon S, Pruvost S, Karaz S, Fabre P, Molina T. 2022. An engineered multicellular stem cell niche for the 3D derivation of human myogenic progenitors from iPSCs. EMBO J. 41(14):e110655.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito F, Yamada H, Hase A, Sunada Y, Shimizu T. 1999. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay? Cell Mol Biol (Noisy-le-grand). 45(6):751–762.
   PubMed Web of Science ®Google Scholar
• Mazaleyrat K, Badja C, Broucqsault N, Chevalier R, Laberthonnière C, Dion C, Baldasseroni L, El-Yazidi C, Thomas M, Bachelier R, Altié A. 2020. Multilineage differentiation for formation of innervated skeletal muscle fibers from healthy and diseased human pluripotent stem cells. Cells. 9(6).
   PubMed Web of Science ®Google Scholar
• Miura Y, Sato M, Kuwahara T, Ebata T, Tabata Y, Sakurai H. 2022. Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice. PLoS One. 17(4):e0266391.
   PubMed Web of Science ®Google Scholar
• Moradi S, Mahdizadeh H, Šarić T, Kim J, Harati J, Shahsavarani H, Greber B, Moore JB. 2019. Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations. Stem Cell Res Ther. 10(1):341.
   PubMed Web of Science ®Google Scholar
• Morisaka H, Yoshimi K, Okuzaki Y, Gee P, Kunihiro Y, Sonpho E, Xu H, Sasakawa N, Naito Y, Nakada S, et al. 2019. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells. Nat Commun. 10(1):5302.
   PubMedGoogle Scholar
• Mournetas V, Massouridès E, Dupont J, Kornobis E, Polvèche H, Jarrige M, Dorval ARL, Gosselin MRF, Manousopoulou A, Garbis SD, et al. 2021. Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset. J Cachexia Sarcopenia Muscle. 12(1):209–232.
   PubMed Web of Science ®Google Scholar
• Mukund K, Subramaniam S. 2020. Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med. 12(1):e1462.
   PubMed Web of Science ®Google Scholar
• Neco P, Rose B, Huynh N, Zhang R, Bridge JHB, Philipson KD, Goldhaber J. 2010. Sodium-calcium exchange is essential for effective triggering of calcium release in mouse heart. Biophys J. 99(3):755–764.
   PubMed Web of Science ®Google Scholar
• Niggli E. 1999. Localized intracellular calcium signaling in muscle: calcium sparks and calcium quarks. Annu Rev Physiol. 61:311–335.
   PubMed Web of Science ®Google Scholar
• Nozoe KT, Akamine RT, Mazzotti DR, Polesel DN, Grossklauss LF, Tufik S, Andersen ML, Moreira GA. 2016. Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports. Sleep Sci. 9(3):129–133.
   PubMedGoogle Scholar
• Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature. 448(7151):313–317.
   PubMed Web of Science ®Google Scholar
• Osaki T, Uzel SGM, Kamm RD. 2018. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv. 4(10):eaat5847.
   PubMed Web of Science ®Google Scholar
• Pareja-Galeano H, Sanchis-Gomar F, Emanuele E, Gallardo ME, Lucia A. 2016a. Ipscs, a promising tool to restore muscle atrophy. J Cell Physiol. 231(2):259–260.
   PubMed Web of Science ®Google Scholar
• Pareja-Galeano H, Sanchis-Gomar F, Pérez LM, Emanuele E, Lucia A, Gálvez BG, Gallardo ME. 2016b. iPSCs-based anti-aging therapies: Recent discoveries and future challenges. Ageing Res Rev. 27:37–41.
   PubMed Web of Science ®Google Scholar
• Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. 1989. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 337(6203):176–179.
   PubMed Web of Science ®Google Scholar
• Pette D, Staron RS. 1997. Mammalian skeletal muscle fiber type transitions. Int Rev Cytol. 170:143–223.
   PubMedGoogle Scholar
• Philippou A, Xanthis D, Chryssanthopοulos C, Maridaki M, Koutsilieris M. 2020. Heart failure-induced skeletal muscle wasting. Curr Heart Fail Rep. 17(5):299–308.
   PubMed Web of Science ®Google Scholar
• Piga D, Salani S, Magri F, Brusa R, Mauri E, Comi GP, Bresolin N, Corti S. 2019. Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies. Ther Adv Neurol Disord. 12:1756286419833478.
   Web of Science ®Google Scholar
• Pourquie O, Tanoury ZA, Chal J. 2018. The Long Road to Making Muscle In Vitro. Curr Top Dev Biol. 129:123–142.
   PubMed Web of Science ®Google Scholar
• Prior BM, Lloyd PG, Yang HT, Terjung RL. 2003. Exercise-induced vascular remodeling. Exerc Sport Sci Rev. 31(1):26–33.
   PubMed Web of Science ®Google Scholar
• Purslow PP. 2010. Muscle fascia and force transmission. J Bodyw Mov Ther. 14(4):411–417.
   PubMedGoogle Scholar
• Rao L, Qian Y, Khodabukus A, Ribar T, Bursac N. 2018. Engineering human pluripotent stem cells into a functional skeletal muscle tissue. Nat Commun. 9(1):126.
   PubMedGoogle Scholar
• Raymond-Pope CJ, Basten AM, Bruzina AS, McFaline-Figueroa J, Lillquist TJ, Call JA, Greising SM. 2023. Restricted physical activity after volumetric muscle loss alters whole-body and local muscle metabolism. J Physiol. 601(4):743–761.
   PubMed Web of Science ®Google Scholar
• Rodriques SG, Stickels RR, Goeva A, Martin CA, Murray E, Vanderburg CR, Welch J, Chen LM, Chen F, Macosko EZ. 2019. Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution. Science. 363(6434):1463–1467.
   PubMed Web of Science ®Google Scholar
• Rowland LP. 1985. Gene expression in muscle. In: Strohman C, Wolf S, editors. Advances in Experimental Medicine and Biology. Springer Nature City: London; p. 3–5.
   Google Scholar
• Sakai-Takemura F, Narita A, Masuda S, Wakamatsu T, Watanabe N, Nishiyama T, Nogami K, Blanc M, Takeda S, Miyagoe-Suzuki Y. 2018. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors. Sci Rep. 8(1):6555.
   PubMedGoogle Scholar
• Sambasivan R, Kuratani S, Tajbakhsh S. 2011a. An eye on the head: the development and evolution of craniofacial muscles. Development. 138(12):2401–2415.
   PubMed Web of Science ®Google Scholar
• Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B, Guenou H, Malissen B, Tajbakhsh S, Galy A. 2011b. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development. 138(17):3647–3656.
   PubMed Web of Science ®Google Scholar
• Sandow A. 1952. Excitation-contraction coupling in muscular response. Yale J Biol Med. 25(3):176–201.
   PubMed Web of Science ®Google Scholar
• Sato T. 2020. Induction of skeletal muscle progenitors and stem cells from human induced pluripotent stem cells. J Neuromuscul Dis. 7(4):395–405.
   PubMedGoogle Scholar
• Scharner J, Zammit PS. 2011. The muscle satellite cell at 50: the formative years. Skelet Muscle. 1(1):28.
   PubMedGoogle Scholar
• Selvaraj S, Mondragon-Gonzalez R, Xu B, Magli A, Kim H, Lainé J, Kiley J, Mckee H, Rinaldi F, Aho J, Tabti N. 2019. Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes. Elife. 8.
   Web of Science ®Google Scholar
• Shayan M, Huang NF. 2020. Pre-Clinical cell therapeutic approaches for repair of volumetric muscle loss. Bioengineering (Basel). 7(3).
   Google Scholar
• Shelton M, Kocharyan A, Liu J, Skerjanc IS, Stanford WL. 2016. Robust generation and expansion of skeletal muscle progenitors and myocytes from human pluripotent stem cells. Methods. 101:73–84.
   PubMed Web of Science ®Google Scholar
• Siegel AL, Kuhlmann PK, Cornelison DD. 2011. Muscle satellite cell proliferation and association: new insights from myofiber time-lapse imaging. Skelet Muscle. 1(1):7.
   PubMedGoogle Scholar
• Suleski IS, Smith R, Vo C, Scriba CK, Saker S, Larmonier T, Malfatti E, Romero NB, Houweling PJ, Nowak KJ, et al. 2022. Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene. Stem Cell Res. 63:102830.
   PubMed Web of Science ®Google Scholar
• Suman S, Domingues A, Ratajczak J, Ratajczak MZ. 2019. Potential Clinical Applications of Stem Cells in Regenerative Medicine. Adv Exp Med Biol. 1201:1–22.
   PubMed Web of Science ®Google Scholar
• Sun C, Choi IY, Gonzalez YIR, Andersen P, Talbot Jr CC, Iyer SR, Lovering RM, Wagner KR, Lee G. 2020. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice. JCI Insight. 5(11).
   Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131(5):861–872.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126(4):663–676.
   PubMed Web of Science ®Google Scholar
• Takeshita E, Minami N, Minami K, Suzuki M, Awashima T, Ishiyama A, Komaki H, Nishino I, Sasaki M. 2017. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions. Neuromuscul Disord. 27(6):569–573.
   PubMed Web of Science ®Google Scholar
• Tanaka KK, Hall JK, Troy AA, Cornelison DDW, Majka SM, Olwin BB. 2009. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell. 4(3):217–225.
   PubMed Web of Science ®Google Scholar
• Tedesco FS, Gerli MF, Perani L, Benedetti S, Ungaro F, Cassano M, Antonini S, Tagliafico E, Artusi V, Longa E, Tonlorenzi R. 2012. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med. 4(140):140ra89.
   PubMedGoogle Scholar
• Uchimura T, Otomo J, Sato M, Sakurai H. 2017. A human iPS cell myogenic differentiation system permitting high-throughput drug screening. Stem Cell Res. 25:98–106.
   PubMed Web of Science ®Google Scholar
• Uchimura T, Otomo J, Sato M, Sakurai H. 2020. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. Biol Res. 53(1):22.
   PubMed Web of Science ®Google Scholar
• Valetdinova KR, Maretina MA, Vyatkin YV, Perepelkina MP, Egorova AA, Baranov VS, Kiselev AV, Gershovich PM, Zakian SM. 2020. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem Cell Res. 48:101941.
   PubMed Web of Science ®Google Scholar
• van der Wal E, Herrero-Hernandez P, Wan R, Broeders M, in 't Groen SLM, van Gestel TJM, van IJcken WFJ, Cheung TH, van der Ploeg AT, Schaaf GJ, Pijnappel WWMP. 2018. Large-Scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies. Stem Cell Rep. 10(6):1975–1990.
   PubMed Web of Science ®Google Scholar
• Van Ruiten HJA, Marini Bettolo C, Cheetham T, Eagle M, Lochmuller H, Straub V, Bushby K, Guglieri M. 2016. Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England. Eur J Paediatr Neurol. 20(6):904–909.
   PubMed Web of Science ®Google Scholar
• Vaughan M, Lamia KA. 2019. Isolation and differentiation of primary myoblasts from mouse skeletal muscle explants. J Vis Exp. 152.
   Google Scholar
• Vicenti G, Bortone I, Bizzoca D, Sardone R, Belluati A, Solarino G, Moretti B. 2020. Bridging the gap between serum biomarkers and biomechanical tests in musculoskeletal ageing. J Biol Regul Homeost Agents. 34(4 Suppl. 3):263–274. Congress of the Italian Orthopaedic Research Society.
   PubMedGoogle Scholar
• Vila OF, Chavez M, Ma SP, Yeager K, Zholudeva LV, Colón-Mercado JM, Qu Y, Nash TR, Lai C, Feliciano CM, et al. 2021. Bioengineered optogenetic model of human neuromuscular junction. Biomaterials. 276:121033.
   PubMed Web of Science ®Google Scholar
• Vila OF, Uzel SGM, Ma SP, Williams D, Pak J, Kamm RD, Vunjak-Novakovic G. 2019. Quantification of human neuromuscular function through optogenetics. Theranostics. 9(5):1232–1246.
   PubMed Web of Science ®Google Scholar
• Wang J, Conboy I. 2010. Embryonic vs. adult myogenesis: challenging the ‘regeneration recapitulates development’ paradigm. J Mol Cell Biol. 2(1):1–4.
   PubMed Web of Science ®Google Scholar
• Wang YX, Rudnicki MA. 2011. Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol. 13(2):127–133.
   PubMed Web of Science ®Google Scholar
• Washington TA, Wolchok JC. 2023. Prescribing reduced physical activity following volumetric muscle loss not really a good idea. J Physiol. 601(7):1157–1158.
   PubMed Web of Science ®Google Scholar
• Wei CW, Luo T, Zou SS, Wu AS. 2018. The role of long noncoding RNAs in central nervous system and neurodegenerative diseases. Front Behav Neurosci. 12:175.
   PubMed Web of Science ®Google Scholar
• Werneck LC, Lorenzoni PJ, Ducci RD-P, Fustes OH, Kay CSK, Scola RH. 2019. Duchenne muscular dystrophy: an historical treatment review. Arq Neuropsiquiatr. 77(8):579–589.
   PubMed Web of Science ®Google Scholar
• Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 448(7151):318–324.
   PubMed Web of Science ®Google Scholar
• Willi L, Abramovich I, Fernandez-Garcia J, Agranovich B, Shulman M, Milman H, Baskin P, Eisen B, Michele DE, Arad M, Binah O. 2022. Bioenergetic and metabolic impairments in induced pluripotent stem cell-derived cardiomyocytes generated from duchenne muscular dystrophy patients. Int J Mol Sci. 23(17).
   PubMed Web of Science ®Google Scholar
• Wu J, Matthias N, Bhalla S, Darabi R. 2021. Evaluation of the therapeutic potential of human iPSCs in a murine model of VML. Mol Ther. 29(1):121–131.
   PubMed Web of Science ®Google Scholar
• Wu J, Matthias N, Lo J, Ortiz-Vitali JL, Shieh AW, Wang SH, Darabi R. 2018. A myogenic double-reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors. Cell Rep. 25(7):1966–1981e4.
   PubMed Web of Science ®Google Scholar
• Xuan W, Khan M, Ashraf M. 2021. Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle. Stem Cell Res Ther. 12(1):131.
   PubMed Web of Science ®Google Scholar
• Xuan W, Tipparaju SM, Ashraf M. 2022. Extracellular vesicles from iPSC derived muscle progenitor cells rejuvenate the dysfunctional muscle stem cells during aging. FASEB J. 36(S1).
   PubMedGoogle Scholar
• Yasutake H, Lee J-K, Hashimoto A, Masuyama K, Li J, Kuramoto Y, Higo S, Hikoso S, Hidaka K, Naito AT, et al. 2021. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes. Sci Rep. 11(1):10351.
   PubMed Web of Science ®Google Scholar
• Yin H, Price F, Rudnicki MA. 2013. Satellite cells and the muscle stem cell niche. Physiol Rev. 93(1):23–67.
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Ito A, Kawabe Y, Kamihira M. 2020. Novel neuromuscular junction model in 2D and 3D myotubes co-cultured with induced pluripotent stem cell-derived motor neurons. J Biosci Bioeng. 129(4):486–493.
   PubMed Web of Science ®Google Scholar
• Young C, Hicks M, Ermolova N, Nakano H, Jan M, Younesi S, Karumbayaram S, Kumagai-Cresse C, Wang D, Zack J, et al. 2016. A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell. 18(4):533–540.
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318(5858):1917–1920.
   PubMed Web of Science ®Google Scholar
• Zablocka B, Gorecki DC, Zablocki K. 2021. Disrupted calcium homeostasis in duchenne muscular dystrophy: A common mechanism behind diverse consequences. Int J Mol Sci. 22(20).
   Web of Science ®Google Scholar
• Zaynitdinova MI, Lavrov AV, Smirnikhina SA. 2021. Animal models for researching approaches to therapy of Duchenne muscular dystrophy. Transgenic Res. 30(6):709–725.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Y, Hu Q, Xi Y, Xing Z, Zhang Z, Huang L, Wu J, Liang K, Nguyen TK, et al. 2020. The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin. Nat Cell Biol. 22(11):1332–1345.
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang Z-N, Rong Z, Xu Y. 2011. Immunogenicity of induced pluripotent stem cells. Nature. 474(7350):212–215.
   PubMed Web of Science ®Google Scholar